Cell Therapeutics Inc

This page shows the latest Cell Therapeutics Inc news and features for those working in and with pharma, biotech and healthcare.

CTI launches cancer drug Pixuvri in UK

Cell Therapeutics Inc (CTI) has launched its cancer treatment Pixuvri in the UK. ... Pixuvri (pixantrone) becomes the first drug available in the UK as a monotherapy treatment option for adults with multiply relapsed or refractory aggressive B-cell

Latest news

Baxter licenses cancer drug from CTI in $172m deal

Cell Therapeutics Inc (CTI) has met its objective of finding a commercial partner for cancer candidate pacritinib by the end of the year, licensing rights to the drug to Baxter for
Gilead expands in cancer with $510m YM BioSciences deal

Aside from Jakafi, other JAK inhibitors being developed for myelofibrosis include Sanofi's selective JAK2 inhibitor SAR302503 - phase II data for which were presented at ASH - and Cell Therapeutics Inc's
ASH meeting hears of progress with myelofibrosis drugs

The absentee at ASH this year among the myelofibrosis candidates was Cell Therapeutics Inc's recently-licensed pacritinib, which like Sanofi's drug is a selective JAK2 inhibitor and has also
Cell Therapeutics pulls Pixuvri filing for non-Hodgkin's lymphoma

Cell Therapeutics pulls Pixuvri filing for non-Hodgkin's lymphoma. Additional time needed to prepare for FDA review. ... Cell Therapeutics Inc (CTI) has withdrawn its marketing application of non-Hodgkin's lymphoma (NHL) drug candidate Pixuri (pixantrone)

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch February 2016

licence, collaboration expanded. 830. Adaptimmune Therapeutics/ GSK. TCR engineered T-cell therapies inc affinity enhanced T-cell immunotherapy targeting NY-ESO-1 (p1/2); 4 other progs and combination studies. ... acquisition - product. 190. Annapurna

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Experienced Editor, London, Medical Communications: Competitive package

Scientific Team Lead: Competitive Salary

Editorial Director – Medical Education: Neg

Account Manager, Healthcare Advertising: Salary TBC

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Director Healthcare PR Communications: Salary TBC

Senior Account Executive – Medical Communications: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Account Director - Digital: Great salary and benefits

Director – Head of Public Affairs: Neg

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director – Global Healthcare PR: Salary TBC

Scientific Director: Highly Competitive Salary &Benefits

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Associate Medical Director: Highly Competitive

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Senior Medical Writer (Remote Working): Competitive Salary Offered

Project / Account Manager (Medical Education): Salary TBC

Account Director: Negotiable

Associate Medical Director: Salary TBC

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies: Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?: Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe’s leading hub for life sciences innovation...